Search Results - Urbanski, Raymond W

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives on the future

    An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives... by Qin, Albert, Urbanski, Raymond W, Yu, Lennex, Ahmed, Tasfia, Mascarenhas, John

    Published in Frontiers in oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A Phase 3b, Single-Arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Ropeginterferon Alfa-2b-Njft (P1101) in Adult Patients with Polycythemia Vera

    A Phase 3b, Single-Arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Ropeginterferon Alfa-2b-Njft (P1101) in Adult Patients with Polycythemia Vera by Mascarenhas, John, Zagrijtschuk, Oleh, Zimmerman, Craig, Qin, Albert, Urbanski, Raymond W

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Comparing Common Therapies in Polycythemia Vera (PV): A Disproportionality Analysis in the FDA Adverse Event Reporting System (FAERS) Database

    Comparing Common Therapies in Polycythemia Vera (PV): A Disproportionality Analysis in the FDA Adverse Event Reporting System (FAERS) Database by Snopek, Frank, Seddighzadeh, Ali, Flynn, Megan, Cai, Ling-Yu, Chen, Esther, Shih, Weichung Joe, Qin, Albert, Urbanski, Raymond W

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: